The global intravenous equipment market (静脈内機器市場) is currently valued at US$ 12.3 billion and is projected to grow steadily at a compound annual growth rate (CAGR) of 5.6% to reach US$ 16.1 billion by 2027. Intravenous equipment facilitates the direct delivery of nutrients or pharmaceuticals, including insulin, hormones, chemotherapy drugs, antibiotics, and pain relievers, into the bloodstream. With the placement of an IV cannula into a vein, medical professionals can administer medications, fluids, or blood without the need for a new needle for each treatment. The market is categorized by various products, including IV catheters, securement devices, administration sets, infusion sets, drip chambers, and others. IV catheters, in particular, are in high demand due to their ability to minimize complications during medical procedures. Peripheral IVs, central venous catheters, and midline catheters are the primary subcategories within the IV catheter segment. Hospitals rely on a variety of IV catheters daily, each serving different purposes depending on the catheter type.

Get Sample PDF of This Research Report with Detailed Table of Content:

https://www.factmr.com/connectus/sample?flag=S&rep_id=7710

One of the main factors driving the demand for intravenous equipment globally is the rising importance of intravenous (IV) therapy. IV therapy is frequently administered to both surgical and non-surgical patients and is a crucial part of the treatment of many disorders. Another important reason propelling the expansion of the global intravenous equipment market is the rising prevalence of chronic diseases across the world. Cancer, heart disease, lung disease, kidney disease, and diabetes are examples of the most prevalent chronic diseases. Furthermore, the development of healthcare infrastructure in underdeveloped nations has opened up attractive potential opportunities for intravenous equipment suppliers.

High Use of Intravenous Equipment in Treatment of Several Serious Diseases”

It is predicted that the need for surgical treatments will increase steadily due to an ageing population with chronic conditions. One of the greatest options for such disorders is IV therapy equipment, which could be advantageous for suppliers of intravenous equipment.

Numerous drugs, including those for rheumatoid arthritis, osteoporosis, Crohn's disease, systemic lupus, psoriasis, multiple sclerosis, and gout, are administered via IV treatment.

Growing prevalence of chronic diseases, the increasing number of surgeries performed globally, the growing amount of intravenous (IV) drug approvals, and the growing technological advancements in intravenous devices are all contributing factors to the growth of the IV equipment market.

Key Takeaways from Market Study

• Sales of IV catheters are predicted to rise at a CAGR of 6% from 2022 to 2027 and reach US$ 5 billion by 2027.
• The global intravenous equipment market (정맥 장비 시장) is expected to expand at a CAGR of 5.6% from 2022 to 2027.
• The market in China is anticipated to surge ahead at a CAGR of 9% during the forecast period.
• Securement device sales are predicted to progress at a CAGR of 6.6% during the next five years.

Key Companies Profiled

• Becton, Dickinson and Company
• B. Braun Melsungen AG
• Fresenius SE & Co. KGaA
• Baxter International Inc.
• Smiths Medical
• ICU Medical, Inc.
• C. R. Bard, Inc.
• Terumo Corporation
• Moog, Inc.
• AngioDynamics, Inc.

Winning Strategy

Becton, Dickinson and Company, Terumo Medical Corporation, B. Braun Holding Gmbh & Co. Kg, Teleflex Medical Inc., and Medtronic Inc. are notable suppliers of intravenous systems. 

The first and sole plug suitable/compatible with a microcatheter to occlude arteries up to 8 millimetres in diameter, the AZURTM Vascular Plug, was launched in July 2021, by Terumo Medical Corporation (TMC). In order to slow down or stop blood flow through the peripheral vasculature's arteries, this is used.

Get Customization on this Report for Specific Research Solutions: https://www.factmr.com/connectus/sample?flag=RC&rep_id=7710

Competitive Landscape

The market's major players are concentrating on integrating IV equipment such as IV infusion pumps with EHR technology.

Manufacturers of intravenous equipment are concentrating on leading economies to expand their market presence globally in light of the rapid growth in the healthcare sector.

A privately-owned company with its headquarters in Salamanca, Spain, Cytognos specializes in flow cytometry technologies for the diagnosis of blood cancer, detection of minimal residual disease, & immune monitoring study for blood disorders. In February 2022, BD (Becton, Dickinson and Company) announced its acquisition of Cytognos.

Intravenous Equipment (Markt für intravenöse Geräte) Industry Research Segmentation

• By Product :
  • IV Catheters
  • Securement Devices
  • Administration Sets
  • Infusion Sets
  • Drip Chambers
  • Others
• End User :
  • Hospitals
  • Clinics
  • Ambulatory Care Centers
  • Others
• By Region :
  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia & Oceania
  • MEA

About Fact.MR :

We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client’s satisfaction.

Contact:

US Sales Office

11140 Rockville Pike

Suite 400 Rockville, MD 20852

United States Tel: +1 (628) 251-1583, +353-1-4434-232 (D)

Sales Team: sales@factmr.com